Mirum Pharmaceuticals, Inc. (MIRM) Total liabilities 2020–2025
Mirum Pharmaceuticals, Inc. (MIRM) total liabilities at each fiscal year-end, per SEC filings.
$528.1MFY2025 · since FY2020: $68.8M → $528.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $528.1M | +18.6% |
| FY2024 | $445.1M | +11.9% |
| FY2023 | $398.0M | +88.7% |
| FY2022 | $210.9M | +20.9% |
| FY2021 | $174.4M | +153.7% |
| FY2020 | $68.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice